Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford Medical Alumni

Social media

Oxford Medical Alumni Network

Sign up for mailings - keep in touch with medicine at Oxford.

Update your contact detailsMake sure you receive alumni news and event invitations.


News from the Medical Sciences Division

Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn

OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.

The GEKO trial launches to bridge the gap in knee osteoarthritis care

A new multicentre trial to evaluate a minimally invasive treatment for patients with knee osteoarthritis could transform the way knee osteoarthritis is managed, potentially improving quality of life for patients long before surgery becomes necessary.

Find out more ...

Oxford Thinking - Report on the Oxford Thinking Campaign 2004-2019

Support the Medical Sciences Department - Development Office

University of Oxford - Alumni Office